BAYRY - Bayer Aktiengesellschaft

Other OTC - Other OTC Delayed Price. Currency in USD
+0.84 (+5.36%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close15.66
Bid0.00 x 0
Ask0.00 x 0
Day's Range15.88 - 16.55
52 Week Range14.61 - 28.19
Avg. Volume992,554
Market Cap61.977B
Beta (3Y Monthly)1.00
PE Ratio (TTM)8.95
Earnings DateN/A
Forward Dividend & Yield0.78 (5.00%)
Ex-Dividend Date2019-04-29
1y Target EstN/A
Trade prices are not sourced from all markets
Press Releases
  • PR Newswire3 months ago

    Settlement Reached Resolving Xarelto Multidistrict Litigation Claims

    NEW ORLEANS, March 25, 2019 /PRNewswire/ -- The makers of the popular blood thinner Xarelto® have reached a $775 million settlement to resolve litigation filed by patients who suffered a bleeding injury after taking the prescription drug. According to the agreement announced earlier today between plaintiff lawyer leadership and Bayer Healthcare (BAYRY) and Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson (JNJ), the settlement is a private agreement intended to resolve the entire litigation including cases in federal and state courts. "This is a fair and just resolution for thousands of consumers who have substantial claims," says Andy Birchfield of the Beasley Allen law firm and co-lead counsel of the Plaintiffs' Steering Committee for the federal multidistrict litigation.

  • Wiivv Partners with Dr. Scholl’s to Deliver Custom 3D Printed Insoles Directly within the United States
    Business Wire6 months ago

    Wiivv Partners with Dr. Scholl’s to Deliver Custom 3D Printed Insoles Directly within the United States

    Wiivv announced today at CES that it is partnering with Dr. Scholl’s, the category leader in foot care, to help expand the 112-year old brand’s business into custom 3D printed insoles, powered by Wiivv Fit Technology. Using a simple smartphone app, consumers can personalize their own design and order--on-demand from their living room--a Dr. Scholl’s Custom 3D printed insole mapped from 400 points on their feet. “Dr. Scholl‘s understands the importance of customization for a growing number of consumers.

  • ACCESSWIRE10 months ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bayer Aktiengesellschaft - BAYRY

    NEW YORK, NY / ACCESSWIRE / August 27, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC PINK: BAYRY). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 9980. The investigation concerns whether Bayer and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

  • PR Newswire10 months ago

    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bayer Aktiengesellschaft (BAYRY)

    NEW YORK , Aug. 20, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bayer Aktiengesellschaft ("Bayer" ...